EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.3.56 | Parkinson Disease |
29607885 |
Association analysis of NUCKS1 and INPP5K polymorphism with Parkinson's disease. |
causal interaction |
2 |
| 3.1.3.56 | Parkinson Disease |
30225765 |
Parkinson's Disease Risk Variant rs1109303 Regulates the Expression of INPP5K and CRK in Human Brain. |
diagnostic usage |
3 |
| 3.1.3.56 | Parkinson Disease |
30225765 |
Parkinson's Disease Risk Variant rs1109303 Regulates the Expression of INPP5K and CRK in Human Brain. |
ongoing research |
1 |
| 3.1.3.56 | Parkinson Disease |
30225765 |
Parkinson's Disease Risk Variant rs1109303 Regulates the Expression of INPP5K and CRK in Human Brain. |
unassigned |
0 |
| 3.1.3.56 | Parkinson Disease |
29607885 |
Association analysis of NUCKS1 and INPP5K polymorphism with Parkinson's disease. |
unassigned |
0 |
| 3.1.3.56 | phosphoinositide 5-phosphatase deficiency |
19736566 |
The role of Arabidopsis 5PTase13 in root gravitropism through modulation of vesicle trafficking. |
causal interaction |
2 |
| 3.1.3.56 | phosphoinositide 5-phosphatase deficiency |
19736566 |
The role of Arabidopsis 5PTase13 in root gravitropism through modulation of vesicle trafficking. |
unassigned |
0 |
| 3.1.3.56 | Spinocerebellar Ataxias |
32107387 |
Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17. |
therapeutic application |
1 |
| 3.1.3.56 | Spinocerebellar Ataxias |
32107387 |
Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17. |
unassigned |
0 |
| 3.1.3.56 | Squamous Cell Carcinoma of Head and Neck |
28696004 |
Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma. |
unassigned |
0 |
